找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Congenital Bleeding Disorders; Diagnosis and Manage Akbar Dorgalaleh Book 2023Latest edition The Editor(s) (if applicable) and The Author(s

[復(fù)制鏈接]
查看: 38912|回復(fù): 55
樓主
發(fā)表于 2025-3-21 17:35:21 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱Congenital Bleeding Disorders
副標(biāo)題Diagnosis and Manage
編輯Akbar Dorgalaleh
視頻videohttp://file.papertrans.cn/236/235475/235475.mp4
概述Offers detailed assistance in the diagnosis and management of bleeding disorders.Includes extensive coverage of rare disorders and the challenges that they pose.Provides up-to-date guidance on use of
圖書(shū)封面Titlebook: Congenital Bleeding Disorders; Diagnosis and Manage Akbar Dorgalaleh Book 2023Latest edition The Editor(s) (if applicable) and The Author(s
描述This significantly updated new edition describes in detail the clinical presentations, diagnosis, and management of a wide range of congenital bleeding disorders. It will assist readers in overcoming the significant challenges involved in clinical and laboratory diagnosis and in providing effective clinical care that makes optimal use of new products, including recombinant factor concentrate. The coverage ranges from hemophilia A and B and von Willebrand disease to rare bleeding disorders such as congenital factor V, factor X, factor XI, and factor XIII deficiency and inherited platelet function disorders. The exceptional attention to rarer conditions is of particular importance given the considerable risk of overlooking them during diagnosis, with potential consequences for disease-related morbidity and mortality. The authors are acknowledged specialists in the field from across the world who have particular expertise in the disorder that they discuss. The book will be of value to hematologists, oncologists, pediatricians, laboratory specialists and technicians, general physicians, and trainees..
出版日期Book 2023Latest edition
關(guān)鍵詞Common Bleeding Disorders; Von Willebrand Disorders; Hemophilia A; Hemophilia B; Rare Bleeding Disorders
版次2
doihttps://doi.org/10.1007/978-3-031-43156-2
isbn_softcover978-3-031-43158-6
isbn_ebook978-3-031-43156-2
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書(shū)目名稱Congenital Bleeding Disorders影響因子(影響力)




書(shū)目名稱Congenital Bleeding Disorders影響因子(影響力)學(xué)科排名




書(shū)目名稱Congenital Bleeding Disorders網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Congenital Bleeding Disorders網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Congenital Bleeding Disorders被引頻次




書(shū)目名稱Congenital Bleeding Disorders被引頻次學(xué)科排名




書(shū)目名稱Congenital Bleeding Disorders年度引用




書(shū)目名稱Congenital Bleeding Disorders年度引用學(xué)科排名




書(shū)目名稱Congenital Bleeding Disorders讀者反饋




書(shū)目名稱Congenital Bleeding Disorders讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:57:58 | 只看該作者
Merete Christiansen,Carsten K. Hansenessment. On-demand therapy is the mainstay of treatment in VWD, although long-term prophylaxis is emerging for those with recurrent and severe bleeding. Therapeutic choices in VWD depend to some extent on geographical location, but include VWF/FVIII concentrates, recombinant VWF, and desmopressin.
板凳
發(fā)表于 2025-3-22 03:36:51 | 只看該作者
地板
發(fā)表于 2025-3-22 08:08:26 | 只看該作者
Christer J?nsson,Jonas Tallbergsma (FFP), plasma-derived FVII (pd-FVII), prothrombin complex concentrate (PCC), activated PCC (aPCC), and more recently, recombinant activated FVII (rFVIIa) are available for treatment of patients with FVII deficiency. New therapeutic options significantly improved the quality of life in patients with congenital FVII deficiency.
5#
發(fā)表于 2025-3-22 11:19:41 | 只看該作者
https://doi.org/10.1007/978-3-030-60679-4aterial positive (CRM+). Different therapeutic choices are available, including fresh frozen plasma and FXI concentrate. However, plasma and factor XI concentrates can provoke inhibitor formation. Recombinant FVIIa treatment can be used for such patients.
6#
發(fā)表于 2025-3-22 15:23:14 | 只看該作者
von Willebrand Disease: An Update on Diagnosis and Treatmentessment. On-demand therapy is the mainstay of treatment in VWD, although long-term prophylaxis is emerging for those with recurrent and severe bleeding. Therapeutic choices in VWD depend to some extent on geographical location, but include VWF/FVIII concentrates, recombinant VWF, and desmopressin.
7#
發(fā)表于 2025-3-22 20:41:56 | 只看該作者
8#
發(fā)表于 2025-3-22 21:30:01 | 只看該作者
Congenital Factor VII Deficiency, Diagnosis, and Managementsma (FFP), plasma-derived FVII (pd-FVII), prothrombin complex concentrate (PCC), activated PCC (aPCC), and more recently, recombinant activated FVII (rFVIIa) are available for treatment of patients with FVII deficiency. New therapeutic options significantly improved the quality of life in patients with congenital FVII deficiency.
9#
發(fā)表于 2025-3-23 01:59:21 | 只看該作者
10#
發(fā)表于 2025-3-23 08:21:27 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 07:02
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
辛集市| 文昌市| 成都市| 桂林市| 东台市| 弋阳县| 濉溪县| 常宁市| 宁城县| 永和县| 禄丰县| 铜山县| 滨州市| 正宁县| 吴川市| 繁昌县| 巴林左旗| 湄潭县| 晋中市| 高密市| 木里| 淮北市| 昌乐县| 南岸区| 稻城县| 连云港市| 铜川市| 阜宁县| 汽车| 阿克陶县| 汤原县| 阳江市| 开远市| 留坝县| 清镇市| 德阳市| 扶绥县| 贵港市| 茂名市| 淮阳县| 海南省|